BKH vs CIG

The Advanced Deterministic Scorecard shows a Piotroski F-Score of 6/9, indicating stable financial health, but the absence of an Altman Z-Score limits distress risk assessment. The stock trades above the Graham defensive fair value of $66.70 at $71.68, supported by a forward P/E below sector average and solid dividend yield of 3.74%. Profitability metrics are healthy with strong gross and operating margins, though ROE and ROA are modest. Earnings growth has rebounded recently, but insider selling and weak technical trend signal caution despite analyst buy recommendation.

CIG presents a classic 'value trap' profile, characterized by a weak Piotroski F-Score of 3/9 indicating deteriorating financial health despite trading significantly below its Graham Number ($3.96) and Intrinsic Value ($10.32). While the current P/E of 7.37 is attractive, the Forward P/E of 17.20 suggests a projected collapse in earnings. Furthermore, a dividend payout ratio of 96.83% is unsustainable and poses a high risk of cuts. The disconnect between deep value metrics and poor fundamental health/analyst 'underperform' ratings warrants a neutral stance.